Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Burkard

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
BMJ Nutrition, Prevention & Health|January 24, 2024
Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: a predefined secondary analysis of a randomised trialFabienne Baur, Cihan Atila, Sophia Lengsfeld, et al.
Kidney & Blood Pressure Research|April 21, 2025
Monotherapy Blood Pressure Response and Control Rates in Treatment-Naïve Patients with Arterial Hypertension: A Randomized Comparison of Four Different Antihypertensive Drug ClassesAnnina Salome Vischer, Maria Bertsch, Vera Van der Velpen, et al.
Diagnostics (Basel, Switzerland)|June 4, 2020
Analyzing 24-Hour Blood Pressure Measurements with a Novel Cuffless Pulse Transit Time Device in Clinical Practice-Does the Software for Heartbeat Detection Matter?Leo Kilian, Philipp Krisai, Thenral Socrates, et al.
Hypertension (Dallas, Tex. : 1979)|April 11, 2020
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese IndividualsSandrine Andrea Urwyler, Fahim Ebrahimi, Thilo Burkard, et al.
American Heart Journal|December 15, 2020
iPhone App compared with standard blood pressure measurement -The iPARR trialMarcus Dörr, Stefan Weber, Ralf Birkemeyer, et al.
European Journal of Heart Failure|July 10, 2012
Why and how do elderly patients with heart failure die? Insights from the TIME-CHF studyPeter Rickenbacher, Matthias Pfisterer, Thilo Burkard, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 13, 2023
A Comprehensive Secondary Prevention Benchmark (2PBM) Score Identifying Differences in Secondary Prevention Care in Patients After Acute Coronary SyndromeMatthias Haegele, Yu-Ching Liu, Simon Frey, et al.
JCI Insight|November 22, 2023
Effects of dulaglutide on alcohol consumption during smoking cessationLeila Probst, Sophie Monnerat, Deborah R Vogt, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 3, 2016
Smart detection of atrial fibrillation†Lian Krivoshei, Stefan Weber, Thilo Burkard, et al.
European Journal of Preventive Cardiology|March 4, 2025
Blood pressure changes during smoking cessation in a randomized, double-blind, placebo-controlled trial of dulaglutide treatmentJulia Beck, Flavia Hasenböhler, Laura Werlen, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
BMJ Nutrition, Prevention & Health|January 24, 2024
Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: a predefined secondary analysis of a randomised trialFabienne Baur, Cihan Atila, Sophia Lengsfeld, et al.
Kidney & Blood Pressure Research|April 21, 2025
Monotherapy Blood Pressure Response and Control Rates in Treatment-Naïve Patients with Arterial Hypertension: A Randomized Comparison of Four Different Antihypertensive Drug ClassesAnnina Salome Vischer, Maria Bertsch, Vera Van der Velpen, et al.
Diagnostics (Basel, Switzerland)|June 4, 2020
Analyzing 24-Hour Blood Pressure Measurements with a Novel Cuffless Pulse Transit Time Device in Clinical Practice-Does the Software for Heartbeat Detection Matter?Leo Kilian, Philipp Krisai, Thenral Socrates, et al.
Hypertension (Dallas, Tex. : 1979)|April 11, 2020
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese IndividualsSandrine Andrea Urwyler, Fahim Ebrahimi, Thilo Burkard, et al.
American Heart Journal|December 15, 2020
iPhone App compared with standard blood pressure measurement -The iPARR trialMarcus Dörr, Stefan Weber, Ralf Birkemeyer, et al.
European Journal of Heart Failure|July 10, 2012
Why and how do elderly patients with heart failure die? Insights from the TIME-CHF studyPeter Rickenbacher, Matthias Pfisterer, Thilo Burkard, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 13, 2023
A Comprehensive Secondary Prevention Benchmark (2PBM) Score Identifying Differences in Secondary Prevention Care in Patients After Acute Coronary SyndromeMatthias Haegele, Yu-Ching Liu, Simon Frey, et al.
JCI Insight|November 22, 2023
Effects of dulaglutide on alcohol consumption during smoking cessationLeila Probst, Sophie Monnerat, Deborah R Vogt, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 3, 2016
Smart detection of atrial fibrillation†Lian Krivoshei, Stefan Weber, Thilo Burkard, et al.
European Journal of Preventive Cardiology|March 4, 2025
Blood pressure changes during smoking cessation in a randomized, double-blind, placebo-controlled trial of dulaglutide treatmentJulia Beck, Flavia Hasenböhler, Laura Werlen, et al.
Pageof 8